Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
The DESKTOPIII trial in platinum-sensitive ovarian cancer

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.01.18
Views: 935

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

Prof Kehoe speaks with ecancer at the 10th BGICC in Cairo about the DESKTOPIII trial comparing the efficacy of additional tumour debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer.

With survival endpoints not yet reached, he describes the improved survival and quality of life seen in the trial as encouraging for relapsed patients.

Prof Kehoe also discussed the fallopian tube as a site of primary lesions here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation